Cancer stem cells targeting agents--a review

Area of Science:

• Oncology
• Cancer Stem Cell Biology

Background:

• Conventional cancer therapies (surgery, radiotherapy, chemotherapy) face significant challenges.
• Treatment failure is often linked to cancer recurrence and mortality.
• Cancer recurrence is frequently attributed to drug-resistant cancer stem cells (CSCs).

Purpose of the Study:

• To review novel therapeutic agents targeting cancer stem cells.
• To discuss the mechanisms by which these agents combat CSCs.
• To address the need for improved cancer treatment strategies overcoming resistance.

Main Methods:

• Literature review of recent studies on CSC-targeting agents.
• Analysis of mechanisms of action for agents like salinomycin and apopotin.
• Discussion of the role of CSCs in therapeutic resistance.

Main Results:

• Identification of specific agents (e.g., salinomycin, apopotin) with CSC-targeting potential.
• Elucidation of mechanisms by which these agents affect CSCs.
• Highlighting the critical role of CSCs in treatment resistance.

Conclusions:

• Targeting cancer stem cells is a promising strategy to overcome therapeutic resistance.
• Novel agents like salinomycin and apopotin offer potential for improved cancer treatment.
• Further research into CSC-targeting therapies is warranted to reduce cancer recurrence and mortality.